Our previous study demonstrated that Rgs5 transgenic mice were resistant to cardiac hypertrophy and fibrosis through inhibition of MEK-ERK1/2 signaling, whereas Rgs5−/− mice displayed the opposite phenotype in response to pressure overload [15]. The gene discussed is MAPK3; the disease is cardiac hypertrophy.